Abstract
Use of doxycycline to prevent sexually transmitted infections (STIs) may lead to antimicrobial resistance. We analyzed attitudes toward this practice between US providers who commonly and less commonly treat STIs. Providers who more commonly treat STIs are more likely to prescribe prophylactic doxycycline and believe that benefits outweigh potential for increased antimicrobial resistance.
Cite
CITATION STYLE
Pearson, W. S., Emerson, B., Hogben, M., & Barbee, L. (2024). Use of Doxycycline to Prevent Sexually Transmitted Infections According to Provider Characteristics. Emerging Infectious Diseases, 30(1), 197–199. https://doi.org/10.3201/eid3001.231152
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.